Recent coverage of our peer-reviewed research, in the healthcare and mainstream press.
Several outlets covered a study by The Dartmouth Institute for Health Policy and Clinical Practice, which appears in the May issue of The American Journal of Managed Care (AJMC). As Emily Rappleye reported in Becker’s Hospital Review, researchers gauging physician awareness of the Choosing Wisely campaign found that while 92% felt a responsibility to control medical costs, only 37% felt they understood how much tests and procedures should cost. For the full study, led by Carrie H. Colla, PhD, click here.
A 2011 AJMC study led by William Boulding, PhD, which found that patient perception of care is an important predictor of 30-day readmission, was featured in the update, “The Patient Experience: Does This Really Matter?” in Health Leaders. Dan Smith, MD, FACEP, medical director of the Studer Group, discussed how providers who make patient experience a priority will stand out as transparency and accountability become more important. For the original AJMC study, click here.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
CMS released a final rule to help patients obtain Children’s Health Insurance Program (CHIP) coverage and issued a proposed rule to update Medicare payment policies and rates for inpatient rehabilitation facilities; debate over if gift card incentives are acceptable in health care marketing.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Dr Chakra Chaulagain: PFS Is the "Bare Minimum," but OS Is Ideal for Choosing Between MM Therapies
March 28th 2024Response rates are important when choosing between therapies to treat multiple myeloma (MM), but improvement overall survival (OS) is the ideal, said Chakra Chaulagain MD, FACP, hematologist/oncologist, Maroone Cancer Center of Cleveland Clinic Florida.
Read More